An In Vivo Confocal Microscopy Analysis of Effects of Topical Antiglaucoma Therapy With Preservative on Corneal Innervation and Morphology

American Journal of Ophthalmology

Volumn 147, Issue 4, 2009, Pages

  Martone, Gianluca ^a   Frezzotti, Paolo ^a   Tosi, Gian Marco ^a   Traversi, Claudio ^a   Mittica, Vincenzo ^a   Malandrini, Alex ^a   Pichierri, Patrizia ^a   Balestrazzi, Angelo ^a   Motolese, Paolo Alfonso ^a   Motolese, Ilaria ^a   Motolese, Edoardo ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LATANOPROST; LATANOPROST PLUS TIMOLOL; TIMOLABAK; TIMOLOL MALEATE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EYE EXAMINATION; FEMALE; HUMAN; IN VIVO STUDY; INTRAOCULAR HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL;

EID: 62649134213     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2008.10.019     Document Type: Article

References (46)

1. Gordon M.O., Beiser J.A., Brandt J.D., et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120 (2002) 701-713
2. Heijl A., Leske M.C., Bengtsson B., et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 120 (2002) 1268-1279
3. Pisella P.J., Pouliquen P., and Baudouin C. Prevalence of ocular symptoms and signs with preserved and preservative-free glaucoma medication. Br J Ophthalmol 86 (2002) 418-423
4. Jaenen N., Baudouin C., Pouliquen P., et al. Ocular symptoms and signs with preserved and preservative-free glaucoma medications. Eur J Ophthalmol 17 (2007) 341-349
5. Baudouin C., Pisella P.J., Fillacier K., et al. Ocular surface inflammatory changes induced by topical antiglaucoma drugs. Ophthalmology 106 (1999) 556-563
6. Wilson L.A. To preserve or not to preserve, is that the question?. Br J Ophthalmol 80 (1996) 583-584
7. Noecker R. Effects of common ophthalmic preservatives on ocular health. Adv Ther 18 (2001) 205-215
8. Champeau E.J., and Edelhauser H.F. Effect of ophthalmic preservatives on the ocular surface: conjunctival and corneal uptake and distribution of benzalkonium chloride and chlorhexidine digluconate. In: Holly F., Lamberts D., and Mac Keen D. (Eds). The preocular tear film in health, disease, and contact lens wear (1998), Lubbock, Texas: Dry Eye Institute Inc 292-302
9. Becquet F., Goldschild M., Moldovan M.S., et al. Histopathological effects of topical ophthalmic preservatives on rat corneoconjunctival surface. Curr Eye Res 17 (1998) 419-425
10. De Saint Jean M., Debbasch F., Brignole P., et al. Toxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cells. Curr Eye Res 20 (2000) 85-94
11. Cha S.H., Lee J.S., Oum B.S., and Kim C.D. Corneal epithelial cellular dysfunction from benzalkonium chloride (BAC) in vitro. Clin Experiment Ophthalmol 32 (2004) 180-184
12. Oliveira-Soto L., and Efron N. Morphology of corneal nerves using confocal microscopy. Cornea 20 (2001) 374-384
13. Herreras J.M., Pastor C., Calonge M., and Asensio V.M. Ocular surface alteration after long-term treatment with an antiglaucomatous drug. Ophthalmology 99 (1992) 1082-1088
14. Shimazaki J., Hanada K., Yagi Y., et al. Changes in ocular surface caused by antiglaucomatous eye drops: prospective, randomised study for the comparison of 0.5% timolol vs. 0.12% unoprostone. Br J Ophthalmol 84 (2000) 1250-1254
15. Inoue K., Okugawa K., Kato S., et al. Ocular factors relevant to antiglaucomatous eye drop-related keratoepitheliopathy. J Glaucoma 12 (2003) 480-485
16. van Buskirk E.M. Adverse reactions from timolol administration. Ophthalmology 87 (1980) 447-450
17. Kuppens E.V., Stolwijk T.R., de Keizer R.J., and van Best J.A. Basal tear turnover and topical timolol in glaucoma patients and healthy controls by fluorophotometry. Invest Ophthalmol Vis Sci 33 (1992) 3442-3448
18. Reidy J.J., Zarzour J., Thompson H.W., et al. Effect of topical beta-blockers on corneal epithelial wound healing in the rabbit. Br J Ophthalmol 78 (1994) 377-380
19. Trope G.E., Liu G.S., and Basu P.K. Toxic effects of topically administered Betagan, Betoptic, and Timoptic on regenerating corneal epithelium. J Ocular Pharmacol 4 (1988) 359-366
20. Camras C.B., and The United States Latanoprost Study Group. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma. Ophthalmology 103 (1996) 138-147
21. Alm A., Stjernschantz J., and The Scandinavian Latanoprost Study Group. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. Ophthalmology 102 (1995) 1743-1752
22. Watson P., Stjernschantz J., and The Latanoprost Study Group. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. Ophthalmology 103 (1996) 126-137
23. Warwar R.E., Bullock J.D., and Ballal D. Cystoid macular edema and anterior uveitis associated with latanoprost use. Ophthalmology 105 (1998) 263-268
24. Sudesh S., Cohen E.J., Rapuano C.J., et al. Corneal toxicity associated with latanoprost. Arch Ophthalmol 117 (1999) 539-540
25. Marques Pereira M.L., and Katz L.J. Choroidal detachment after the use of topical latanoprost. Am J Ophthalmol 132 (2001) 928-929
26. Wand M., Gilbert C.M., and Liesegang T.J. Latanoprost and herpes simplex keratitis. Am J Ophthalmol 127 (1999) 602-604
27. Arici M.K., Arici D.S., Topalkara A., et al. Adverse effects of topical antiglaucoma drugs on the ocular surface. Clin Experiment Ophthalmol 28 (2000) 113-117
28. De Saint Jean M., Brignole F., Bringuier A.F., et al. Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells. Invest Ophthalmol Vis Sci 40 (1999) 619-630
29. Green K., Chapman J.M., Cheeks L., et al. Detergent penetration into young and adult rabbit eyes: comparative pharmacokinetics. J Toxicol Cutaneous Ocul Toxicol 6 (1987) 89-107
30. Yee R.W. The effect of drop vehicle on the efficacy and side effects of topical glaucoma therapy: a review. Curr Opin Ophthalmol 18 (2007) 134-139
31. Noecker R.J., Herrygers L.A., and Anwaruddin R. Corneal and conjunctival changes caused by commonly used glaucoma medications. Cornea 23 (2004) 490-496
32. Guenoun J.M., Baudouin C., Rat P., et al. In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctive derived epithelial cells. Invest Ophthalmol Vis Sci 46 (2005) 2444-2450
33. Ubels J.L., McCartney M.D., Lantz W.K., et al. Effects of preservative-free artificial tear solutions on corneal epithelial structure and function. Arch Ophthalmol 113 (1995) 371-378
34. Manni G., Centofanti M., Oddone F., et al. Interleukin-1β tear concentration in glaucomatous and ocular hypertensive patients treated with preservative-free nonselective beta-blockers. Am J Ophthalmol 139 (2005) 72-77
35. Ichijima H., Petroll W.M., Jester J.V., and Cavanagh H.D. Confocal microscopic studies of living rabbit cornea treated with benzalkonium chloride. Cornea 11 (1992) 221-225
36. Berdy G.J., Abelson M.B., Smith L.M., et al. Preservative-free artificial tear preparations. Assessment of corneal epithelial toxic effects. Arch Ophthalmol 110 (1992) 528-532
37. Baudouin C. Allergic reaction to topical eye drops. Curr Opin Allergy Clin Immunol 5 (2005) 459-463
38. Kuppens E.V., de Jong C.A., Stolwijk T.R., et al. Effects of timolol with and without preservative on the basal tear turnover in glaucoma. Br J Ophthalmol 79 (1995) 339-342
39. Thygesen J., Aaen K., Theodorsen F., et al. Short-term effect of latanoprost and timolol eye drops on tear fluid and the ocular surface in patients with primary open-angle glaucoma and ocular hypertension. Acta Ophthalmol Scand 78 (2000) 37-41
40. Baudouin C., Liang H., Hamard P., et al. The ocular surface of glaucoma patients treated over the long-term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways. Ophthalmology 115 (2008) 109-115
41. Zhang M., Chen J., Luo L., Xiao Q., Sun M., and Liu Z. Altered corneal nerves in aqueous tear deficiency viewed by in vivo confocal microscopy. Cornea 24 (2005) 818-824
42. Villani E., Galimberti D., Viola F., et al. The cornea in Sjögren's syndrome: an in vivo confocal study. Invest Ophthalmol Vis Sci 48 (2007) 2017-2022
43. Benitez del Castillo J.M., Wasfy M.A.S., Fernandez C., and Garcia-Sanchez J. An in vivo confocal masked study on corneal epithelium and subbasal nerves in patients with dry eye. Invest Ophthalmol Vis Sci 45 (2004) 3030-3035
44. Grupcheva C.N., Wong T., Riley A.F., and McGhee C.H.J. Assessing the sub-basal nerve plexus of the living healthy human cornea by in vivo confocal microscopy. Clin Experiment Ophthalmol 30 (2002) 187-190
45. Baudouin C. Side effects of antiglaucomatous drugs on the ocular surface. Curr Opin Ophthalmol 7 (1996) 80-86
46. Lavin M.J., Wormald R.P., Migdal C.S., et al. The influence of prior therapy on the success of trabeculectomy. Arch Ophthalmol 108 (1990) 1543-1548